Market Highlights From CapitalHeight.


Apart from relatively stable diesel and petrol prices, car buyers in India have one more reason to cheer, at least for the time being. In a departure from the previous trend, most passenger vehicle makers have refrained from going for an immediate price hike of even as key raw material costs including steel, aluminium, and copper, have risen sharply recently. This is despite the fact that most companies have seen a good volume run, which gives them enough power to introduce price hikes. Passenger vehicle sales in India rose 7.8 per cent to 3.2 million in 2018-19, according to Society of Indian Automobile Manufacturer (SIAM). But most, including volume car makers Maruti Suzuki India and Hyundai Motor India, have chosen to absorb input costs increase, at least for the time being. For More Market Update Click here: CapitalHeight.

    Disappointed over losing the race to acquire Fortis Healthcare, Malaysia's IHH Healthcare said today that it is currently evaluating options while seeking support from shareholders of the Indian firm.IHH Healthcare Managing Director and CEO Tan See Leng claimed that his company's bid offered the highest price and most comprehensive solution and addressed the short-term liquidity requirements and long-term strategic objectives of Fortis. "We are disappointed by the decision made by the Board of Fortis, as we believe we submitted the most compelling bid for the benefit of all Fortis stakeholders," he said in a statement.

Shares of select pharmaceutical companies were under pressure, falling by up to 6% ahead of US President Donald Trump speech today about controlling prescription drug prices.Sun Pharmaceutical Industries slipped 6% to Rs 468 on the BSE in noon deal on back of heavy volumes. Novartis India, Marksans Pharma, Ajanta Pharma, Morepen Laboratories, Alkem Laboratories, Sun Pharma Advanced Research Company (SPARC) and Aarti Drugs were down in the range 3% to 4% on the BSE. For 2 Days Free Trial click here: CapitalHeight.

Comments

Post a Comment

Popular posts from this blog

Making Your First Investment in the Stock Market Through CapitalHeight.

Image
    Lupin received tentative approval from the US health regulator for its Tadalafil tablets, indicated for treating erectile dysfunction and prostate gland enlargement. The clearance from the United States Food and Drug Administration (USFDA) is for marketing Tadalafil tablets in strengths of 2.5 mg, 5 mg, 10 mg, and 20 mg, in the US, Lupin said in a statement. The product is a generic version of Eli Lilly and the company's Cialis tablets in the same strengths, it added.      For Expert Advice Click here: CapitalHeight .         Shares of Hindalco lost around 8 percent afternoon after reports emerged that it is likely to acquire Aleris for USD 2.5 billion. According to sources the company and its Canadian arm, Novelis, is in process of raising debt for the said deal. Investors may have taken note of this point as the firm already has a consolidated net debt of Rs 40,000 crore. Further, the report added that the companies agreed on terms of the deal last week.Hindalco
Read more

Stock market news | Today's business and financial news by CapitalHeight.

Image
Tata Power Company has reported consolidated Q1FY19 net profit at Rs 1,769 crore, which includes one-time gain on sale of its investments of Rs 1,897 crore. The company had posted net profit of Rs 391 crore in the same quarter last fiscal. Revenue of the company was up 14 percent at Rs 7,313 crore against Rs 6,415 crore. Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) was down 8.5 percent at Rs 1,771 crore and margin was down 600 bps at 24.2.      For Expert Advice Click here: CapitalHeight .         Larsen & Toubro (L&T) rose 2 percent in the opening trade on Thursday on the back of robust numbers declared by the company in the quarter ended June 2018 (Q1FY19).The company posted a 13.8 percent year-on-year (YoY) increase in consolidated net profit at Rs 1,213 crore, beating analyst estimates driven by order inflow growth in infrastructure, heavy engineering and hydrocarbon segments. Profit for the same period last year was Rs 1,065.54 crore
Read more

Stop Losses - An Important Part of Stockmarket Trading by CapitalHeight.

Image
Bajaj Auto lost around 8 percent on Friday afternoon as investors turned wary of its results that the company declared. The stock touched an intraday high of Rs 3,152.45 and an intraday low of Rs 2,864.00.India's third largest two-wheeler maker missed analysts' expectations by reporting a 20.7 percent year-on-year rise in its standalone net profit for the quarter ended June. The company's net profit came in at Rs 1,115.23 crore.     For 2 Days Free Trial Click here: CapitalHeight .     The initial public offering (IPO) of TCNS Clothing was subscribed over 2.08 times on Day 3 of bidding so far. The IPO, to raise Rs 1,125-crore, received bids for 2.29 crore shares against the total issue size of 1.09 crore shares, data available with the NSE as of 11:45 am showed. The portion set aside for qualified institutional buyers (QIBs) was subscribed 7 times, non-institutional investors 0.11 times percent and retail investors at 0.12 times. Price band for the offer h
Read more